difluorosialic acid derivatives (University of British Columbia)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedifluorosialic acid derivatives (University of British Columbia)
Drug Alias Nameneuraminidase inhibitors (University of British Columbia)next-generation neuraminidase inhibitors (CDRD/University of British Columbia)next-generation neuraminidase inhibitors (CDRD/University of British Columbia)neuraminidase inhibitors (University of British Columbia/CSIRO/University of Bath)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaAustralia and New ZealandUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of British Columbia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCommonwealth Scientific And Industrial Research Organisation, AustraliaCentre for Drug Research and DevelopmentThe University Of British Columbia +[5] 
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A